Anticoagulation Intensity of Rivaroxaban for Stroke Patients at a Special Low Dosage in Japan

OBJECTIVES: In Japan, low-dose rivaroxaban [15 mg QD/10 mg QD for creatinine clearance of 30–49 mL/min] was approved for clinical use in NVAF patients partly because of its unique pharmacokinetics in Japanese subjects. The aim of the study was to determine the anticoagulation intensity of rivaroxaba...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Okata, Takuya, Toyoda, Kazunori, Okamoto, Akira, Miyata, Toshiyuki, Nagatsuka, Kazuyuki, Minematsu, Kazuo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257912/
https://ncbi.nlm.nih.gov/pubmed/25479967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0113641
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi